Calcium Supplementation News and Research

RSS

Meta-analysis shows calcium supplementation does not raise coronary heart disease in elderly women

The results of a study presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases do not support the hypothesis that calcium supplementation, with or without vitamin D, increases coronary heart disease or all-cause mortality risk in elderly women.

7 Apr 2014

Study: Timing of calcium, vitamin D supplementation affects skeletal adaptations to exercise training

Taking calcium and vitamin D before exercise may influence how bones adapt to exercise, according to a new study. The results will be presented on Tuesday at The Endocrine Society's 95th Annual Meeting in San Francisco.

19 Jun 2013

$USPSTF posts final recommendation statement on vitamin D supplementation to prevent fractures$

USPSTF posts final recommendation statement on vitamin D supplementation to prevent fractures

The U.S. Preventive Services Task Force (USPSTF) has posted its final recommendation statement on vitamin D and calcium supplementation to prevent fractures in adults.

1 Mar 2013

Calcium supplement intake may increase risk of death from heart disease in men

In a new study from the National Institutes of Health, startling results showed that men who took calcium supplements were more apt to die of heart disease than those who didn't get extra calcium in supplement form.

20 Feb 2013

Calcium supplements may increase men’s death risk

Men who have a high intake of supplemental calcium may be at an increased risk for cardiovascular disease death, report researchers.

7 Feb 2013

Calcium link to PHPT shown

Increased calcium intake is associated with a lower risk for primary hyperparathyroidism, shows research published in the BMJ.

19 Oct 2012

Merck announces results from odanacatib Phase II trial on post-menopausal osteoporosis

Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.

15 Oct 2012

$Higher doses of Vitamin D may be most beneficial in reducing bone fractures in older adults$

Higher doses of Vitamin D may be most beneficial in reducing bone fractures in older adults

Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, Bess Dawson-Hughes, MD, director of the Bone Metabolism Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group.

6 Jul 2012

Vitamin D–calcium combo reduces mortality in elderly

The results of a meta-analysis of individual patient data show that vitamin D supplementation with calcium reduces mortality rates in the elderly.

2 Jul 2012

Calcium supplements may increase the risk of heart attack

Calcium supplements might increase the risk of having a heart attack, and should be “taken with caution,” concludes research published in the online issue of the journal Heart.

24 May 2012

Positive top-line results from NPSP558 Phase 3 study on hypoparathyroidism

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced positive top-line results from REPLACE, a Phase 3 registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients.

7 Nov 2011

Calcium supplementation does not benefit pregnant women, except for hypertension

Most physicians instruct pregnant women to increase their calcium intake, but a new evidence review of potential benefits of calcium supplementation for mom and baby found none, except for the prevention of pregnancy-related hypertension.

7 Oct 2011

Higher than IOM recommended Vitamin D levels required for optimizing osteoporosis, low BMD therapy

To fully optimize a drug therapy for osteoporosis and low bone mineral density (BMD), patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine (IOM), according to a new study by researchers from Hospital for Special Surgery in New York. The study will be presented at the Endocrine Society's Annual Meeting in Boston, June 4-7.

7 Jun 2011

Study focuses on calcium intake among U.S. population

Americans may not be getting enough calcium in their diets, according to a new study published in the May 2011 issue of the Journal of the American Dietetic Association.

28 Apr 2011

State court jury rules in favor of Merck in FOSAMAX trial

Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use.

15 Feb 2011

Milk may reduce risk of bowel cancer: Study

Research by Associate Professor Brian Cox and Dr Mary Jane Sneyd of the Otago University’s Hugh Adam cancer epidemiology unit has shown that New Zealand schoolchildren who drank milk daily significantly reduced their chances of getting bowel cancer as adults.

17 Jan 2011

UBC receives $7M grant from Bill & Melinda Gates Foundation for PRE-EMPT Project

The University of British Columbia has received a $7 million grant from the Bill & Melinda Gates Foundation. UBC researchers working at the Child & Family Research Institute will test new strategies for the monitoring, prevention, and treatment of pre-eclampsia.

4 Dec 2010

Merck wins third FOSAMAX bellwether trial

Merck & Co., Inc. today said a federal court jury in New York found in its favor in the Graves v. Merck case, rejecting the claims of a Florida woman who blamed her dental and jaw related problems on her FOSAMAX use. With today's verdict, Merck has won three of the first four bellwether cases in the FOSAMAX litigation.

20 Nov 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 million to $1.5 million but denied Merck's request for judgment in its favor or a new trial in the case of Boles v. Merck, a retrial of a federal FOSAMAX case.

5 Oct 2010